Recent Quotes (30 days)

You have no recent quotes
chg | %

Sirona Biochem Corp.  

(Public, CVE:SBM)   Watch this stock  
Find more results for SBM
0.000 (0.00%)
Mar 26 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.09 - 0.19
Open     -
Vol / Avg. 0.00/1.03M
Mkt cap 23.61M
P/E     -
Div/yield     -
EPS -0.04
Shares 138.88M
Beta -0.26
Inst. own     -
Mar 24, 2015
Sirona Biochem Corp at Biotechnology Industry Organization (BIO) Asia International Conference

Key stats and ratios

Q3 (Jul '14) 2013
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -79.24% -90.35%
Return on average equity -135.39% -141.37%
CDP Score - -


889 Pender St W
+1-604-6414466 (Phone)
+1-604-6085471 (Fax)

Website links


Sirona Biochem Corp. is a Canada-based, development-stage company. Sirona is a product-pipeline company with a proprietary technology platform developed at its laboratory facility in France. The Company specializes in the stabilization of carbohydrate molecules. The Company�s compounds are being developed for both pharmaceutical and cosmetic marketplaces. It is also focused on advancing three programs: therapeutics, which includes sodium glucose co-transporter (SGLT) and cancer antigen; cosmetic agents, which includes skin lightener and anti-aging and biological ingredients, which includes inducers and adjuvants. Its two most advanced programs include a diabetes treatment and a cosmetic skin lightening agent.

Officers and directors

Howard Verrico M.D. Chairman of the Board, Interim Chief Executive Officer, Founder, Secretary
Christopher D. Hopton Chief Financial Officer, Director
Geraldine Deliencourt-Godefroy Chief Scientific Officer, Director
Attila Hajdu Chief Business Development Officer
Martin Gleave Director
Age: 53
David S. Moore Director
Age: 41
Michael Rogers Director
Nigel Andrew Terrett Director
Alex Marazzi Independent Director